Concourse Financial Group Securities’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-430
| Closed | -$29K | – | 11351 |
|
|
2022
Q3 | $29K | Hold |
430
| – | – | ﹤0.01% | 1165 |
|
|
2022
Q2 | $14K | Buy |
430
+165
| +62% | +$5.37K | ﹤0.01% | 1572 |
|
|
2022
Q1 | $9K | Sell |
265
-175
| -40% | -$5.94K | ﹤0.01% | 1734 |
|
|
2021
Q4 | $13K | Sell |
440
-15
| -3% | -$443 | ﹤0.01% | 1791 |
|
|
2021
Q3 | $12K | Hold |
455
| – | – | ﹤0.01% | 1843 |
|
|
2021
Q2 | $16K | Buy |
455
+165
| +57% | +$5.8K | ﹤0.01% | 1718 |
|
|
2021
Q1 | $12K | Hold |
290
| – | – | ﹤0.01% | 1727 |
|
|
2020
Q4 | $13K | Buy |
290
+15
| +5% | +$672 | ﹤0.01% | 1615 |
|
|
2020
Q3 | $15K | Hold |
275
| – | – | ﹤0.01% | 1454 |
|
|
2020
Q2 | $17K | Hold |
275
| – | – | ﹤0.01% | 1355 |
|
|
2020
Q1 | $14K | Hold |
275
| – | – | ﹤0.01% | 1362 |
|
|
2019
Q4 | $22K | Buy |
275
+100
| +57% | +$8K | ﹤0.01% | 1226 |
|
|
2019
Q3 | $8K | Hold |
175
| – | – | ﹤0.01% | 1222 |
|
|
2019
Q2 | $9K | Buy |
+175
| New | +$9K | ﹤0.01% | 1536 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6379 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6292 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6125 |
|